Online Education
- Home
- Online Education
Important Note
You will need to login first in order to enroll or view an activity. Login Here
*Note: ✔ = Contact Hours Provided AND ✖ = No Contact Hours Provided
Plasminogen Deficiency: An Ultra-rare, Multi-system Disease (for HTC staff)
- Credits: 1.0 (ACCME), 1.0 (ANCC)
- Expiration Date: July 21, 2025
Plasminogen Deficiency: An Ultra-rare, Multi-system Disease (for HTC staff) Details
Activity Number and Title
23HT58930-31 Plasminogen Deficiency: An Ultra-rare, Multi-system Disease (for HTC staff)
Release Date
July 21, 2023
Expiration Date
5:00 PM Eastern, July 21, 2025
The estimated time to complete this activity is 60 minutes.
Purpose Statement
The purpose of this enduring material is to enable learners to gain knowledge of the diagnosis and management for plasminogen deficiency, and the treatment and support services available through the US HTC network.
Activity Description
This learning activity presents diagnostic and management considerations for plasminogen deficiency. Additionally, information is offered regarding the first FDA-approved treatment and the importance of the HTC as medical home for patients diagnosed with plasminogen deficiency.
Target Audience
This accredited continuing education activity is designed for multidisciplinary providers at Hemophilia Treatment Centers (HTCs) including physicians, advanced care providers, nurses, pharmacists, and other members of the multidisciplinary care team who might treat a patient presenting with plasminogen deficiency.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Describe the genetic background, pathophysiology, and varied clinical manifestations of type 1 plasminogen deficiency
- Identify treatment options including the first approved specific replacement therapy for plasminogen deficiency
- Analyze patient case-studies that demonstrate the involvement of multiple systems, the path to diagnosis and treatment
- Describe the need for a medical home for multi-disciplinary team-based care through HTCs, that includes ongoing patient monitoring to assure accurate and timely recognition and treatment of emerging issues as well as data collection to advance care
Faculty
- Amy D. Shapiro, MD
- Charles Nakar, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia & Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS/PHYSICIAN ASSISTANTS
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
A School Nurse's Guide to Bleeding Disorders: von Willebrand Disease
- Credits: 0.5 (ANCC)
- Expiration Date: December 29, 2025
A School Nurse's Guide to Bleeding Disorders: von Willebrand Disease Details
Activity Number and Title
23HT00148 A School Nurses Guide to Bleeding Disorders: von Willebrand Disease
Release Date
December 27, 2023
Expiration Date
5:00 PM Eastern, December 29, 2025
The estimated time to complete this activity is 30 minutes.
Purpose Statement
This activity aims to enable the learner to enhance his/her knowledge about von Willebrand disease (VWD), common treatment methods/products, and accommodations recommended to provide a safe and positive learning environment for the student with VWD.
Activity Description
A School Nurses Guide to Bleeding Disorders: von Willebrand Disease contains information about von Willebrand disease (VWD), its treatment, and accommodations that must be made in order to promote a safe and positive learning environment for the student with VWD. This includes a definition of VWD and a description of common symptoms; description of VWD treatment; and exploration of the Hemophilia Treatment Center (HTC) comprehensive care team as an essential resource in managing the student with VWD.
Target Audience
This accredited education activity is designed for professional school nurses in schools. Other care team members may find this education helpful including teachers, PE teachers, school administrators, and guidance counselors, other educators, and other health care professionals.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Apply basic information related to the etiology and symptoms of von Willebrand disease (VWD) to clinical practice with students
- Recognize common treatments utilized for VWD within the school setting
- Integrate strategies in the school setting to promote a safe and positive learning environment
Faculty
- Lisa Bowman, RN, BSN, ASN
- Molly Simmons, RN, BSN
Requirements for Successful Completion
In order to receive continuing education credit, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accredited Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 463-238-1186 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
Physical Therapy in the Care of Persons with Bleeding Disorders
- Credits: 1.5 (ANCC),1.5 (IPCE),0.15 (CPTA)
- Expiration Date: December 1, 2025
Physical Therapy in the Care of Persons with Bleeding Disorders Details
Activity Number and Title
23HT00124 Physical Therapy in the Care of Persons with Bleeding Disorders
Release Date
December 1, 2023
Expiration Date
5:00 PM Eastern, December 1, 2025
The estimated time to complete this activity is 90 minutes.
Purpose Statement
The purpose of this online learning module is to enable the learner to increase their knowledge on the musculoskeletal concerns, potential complications, and physical therapy management of bleeding disorders.
Activity Description
After providing a review of basic information about hemophilia and von Willebrand disease, this learning module describes signs and symptoms of hemophilic bleeding, the complications associated with recurrent bleeding, physical therapy interventions for acute and chronic musculoskeletal complications of hemophilia, and imaging techniques including X-ray, MRI, and musculoskeletal ultrasound, which may be used to assess musculoskeletal status in patients with bleeding disorders.
Target Audience
This accredited continuing education activity is designed for physical therapists, physical therapist assistants, nurses, nurse practitioners, and other health care providers who are involved with the federally recognized U.S. Hemophilia Treatment Center, or HTC, network or otherwise engaged in comprehensive care and/or physical therapy management of individuals with hemophilia and other bleeding disorders.
This activity assumes that the learner possesses fundamental knowledge of the musculoskeletal and neurological systems and a basic understanding of bleeding disorders and the comprehensive care model. Learners who do not meet these criteria may wish to complete the PartnersPRN activity, Understanding Hemophilia, prior to completion of this module on physical therapy and comprehensive care.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Summarize basic information on the clinical picture of hemophilia and von Willebrand disease
- Identify signs and symptoms of acute and chronic musculoskeletal bleeding including hemarthroses and muscle bleeding
- Recognize the complications of recurrent hemarthroses including chronic synovitis, cartilage destruction, and hemophilic arthropathy
- Discuss physical therapy interventions for acute bleeding events and chronic musculoskeletal complications of bleeding disorders and how the multidisciplinary team can help implement these strategies to improve patient outcomes
- Recall imaging techniques and their use to assess musculoskeletal status in patients with bleeding disorders
Faculty
- Stacie Akins, PT, MHS
- Sherry Herman-Hilker, PT, MS
- Jennifer Newman, PT, MSPT
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accredited Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.5 ANCC contact hour(s). Nurses should only claim credit for the actual time spent participating in the activity.
IPCE CREDIT
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
PHYSICAL THERAPISTS
This activity is approved for physical therapy continuing education units (CEUs) through the California Physical Therapy Association (CPTA) (Approved for 0.15 CEUs by CPTA #23-570) from December 1, 2023 to December 1, 2024. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection Internet browser (current version) - Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
Psychosocial Considerations in Bleeding Disorder Care: Aging with Hemophilia
- Credits: 1.25 (ACE), 1.25 (ANCC), 1.25 (IPCE)
- Expiration Date: August 29, 2025
Psychosocial Considerations in Bleeding Disorder Care: Aging with Hemophilia Details
Activity Number and Title
23HT00105 Psychosocial Considerations in Bleeding Disorders Care: Aging with Hemophilia
Release Date
August 29, 2023
Expiration Date
5:00 PM Eastern, August 29, 2025
The estimated time to complete this activity is 75 minutes.
Purpose Statement
The purpose of this activity is to enable learners to provide competent psychosocial support to persons with hemophilia (PWH) as they navigate changes associated with the aging process.
Activity Description
This activity will describe the increasing burden of chronic disease in elderly Americans and the role of extended life expectancy on prevalence of chronic conditions among elderly persons with hemophilia. The activity assesses psychosocial considerations in managing care for elderly persons with hemophilia and recommends practical assessment strategies for use in the Hemophilia Treatment Center environment to optimize care of these individuals.
Target Audience
This accredited continuing education activity is designed for social workers, nurses, and other members of the multidisciplinary comprehensive care team at U.S. federally-recognized hemophilia treatment centers (HTCs) who routinely encounter adult persons with hemophilia (PWH) in need of support to navigate changes associated with the aging process.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Describe the increasing burden of chronic disease among persons aged 65 and over in the United States
- Review the evolution of hemophilia treatment and the associated increase in life expectancy among persons with hemophilia
- Evaluate the prevalence of chronic conditions among aging and elderly persons with hemophilia
- Assess psychosocial considerations pertinent to the care of aging and elderly persons with hemophilia
- Incorporate practical psychosocial assessment strategies in the hemophilia treatment center environment to optimize care of aging and elderly persons with hemophilia
Faculty
- Ellen Kachalsky, LMSW, ACSW, CCM
- Colleen Joiner, LMSW, CCM
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 80% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accreditation Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 1.25 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
As a Jointly Accredited Organization, University of Nebraska Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 clinical continuing. The content level of this activity is advanced.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
Understanding Hemophilia Details
Activity Number and Title
24HT00086 Understanding Hemophilia
Release Date
July 15, 2024
Expiration Date
5:00 PM Eastern, July 15, 2026
The estimated time to complete this activity is 120 minutes.
Purpose Statement
"Understanding Hemophilia" is a 6-part online learning activity that aims to enable clinicians at U.S. Hemophilia Treatment Centers to gain knowledge and develop expertise on the pathogenesis, inheritance, symptoms, potential complications, and clinical management of hemophilia.
Activity Description
This 6-part online learning activity introduces basic concepts of hemophilia.
Part 1: Pathogenesis & Inheritance examines the coagulation system and processes, the deficit in hemophilia that interferes with clot formation, differences among types of hemophilia, and the sex-linked inheritance pattern of hemophilia.
Part 2: Symptoms & Sequelae distinguishes bleeding patterns and clinical presentation of hemophilia based on severity, differentiates types of bleeding episodes, and discusses physical/psychosocial sequelae of hemophilia.
Part 3: Factor Concentrates & Hemophilia Management discusses episodic and prophylactic management of hemophilia with clotting factor concentrate, different factor therapy protocols, and nursing considerations in administration of clotting factor concentrates.
Part 4: Introduction to Inhibitors explains the immune response and inhibitor development, signs/symptoms and risk factors of inhibitors, the impact of inhibitors on persons with hemophilia, inhibitor treatment strategies and challenges, and the positive health outcomes of immune tolerance induction therapy.
Part 5: Non-Factor Therapies covers gene therapy for hemophilia and the novel agent emicizumab. Gene therapy includes goals of therapy, delivery of gene therapy, eligibility criteria, patient readiness considerations pre- and post-therapy, and long-term follow-up post-therapy.
Part 6: Carrier Considerations reviews hemophilia sex-linked genetics and introduces recommendations for the management of carriers and women with hemophilia, neonatal diagnosis and circumcision in males with hemophilia, and key considerations of postpartum management of carriers and women with hemophilia.
Target Audience
This accredited continuing education activity is designed for physical therapists, nurses, nurse practitioners, social workers and other clinical and non-clinical staff at federally recognized U.S. Hemophilia Treatment Centers who wish to develop an understanding of basic concepts of hemophilia. This activity is particularly appropriate for clinicians within their first six months of employment at an HTC.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Describe the pathogenesis and inheritance patterns concerning the different factor deficiencies in hemophilia including the symptoms and sequelae that may occur
- Discuss the target factor levels for situational bleeding episodes in conjunction with the appropriate factor replacement protocols, prophylactic treatments, and nursing considerations in administration of clotting factor concentrates
- Review the development and impact of inhibitors on persons with hemophilia, including signs and symptoms, risk factors, treatment implications, and nursing considerations
- Describe the goals of hemophilia gene therapy and describe the mechanism of action for hemophilia gene therapy
- Summarize the MASAC recommendations on the use of Emicizumab such as the indications, management approaches, and concurrent use with bypassing agents
- Articulate the role of genetic testing in the identification of potential carriers and women with hemophilia and the hemostatic management recommendations during pregnancy, labor and delivery, and the postpartum phases
Faculty
- Jennifer Maahs, MSN, PNP
- Amy Shapiro, MD
Requirements for Successful Completion
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity.
- Complete the evaluation.
- Complete the post-test with a score of 80% or better.
- Upon successful completion of the post-test your certificate of completion will be available to print or save
Accredited Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 2.0 ANCC contact hour(s). This activity is provided for 0.3 contact hours related to pharmacotherapeutic content. Nurses should only claim credit for the actual time spent participating in the activity.
SOCIAL WORKERS
As a Jointly Accredited Organization, University of Nebraska Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 2 clinical continuing education credits. The content level of this activity is beginner.
PHYSICAL THERAPISTS
This activity is approved for physical therapy continuing education units (CEUs) through the California Physical Therapy Association (CPTA) (Approved for 0.2 CEUs by CPTA #24-215) from May 24, 2024 to May 24, 2025. While many states recognize continuing education credits from CPTA, please verify with your state Board that these credits are acceptable in your state. To learn more about CPTA, visit https://www.ccapta.org.
Financial Support
Partners in Bleeding Disorders Education Programs are currently supported by educational grants from Genentech, a member of the Roche Group; Takeda Pharmaceuticals U.S.A., Inc.; and Novo Nordisk.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
The 340B Pharmacy Program and the HTC
- Credits: 0.5 (ANCC)
- Expiration Date: January 9, 2026
The 340B Pharmacy Program and the HTC Details
Special Note
Before completing this module, you may want to complete the PartnersPRN online learning activity titled U.S. Hemophilia Treatment Center Network: The Big Picture or if its no longer available on the site, contact Partners partners@ihtc.org for a copy of the PDF slides.
Activity Number and Title
24HT00069 The 340B Pharmacy Program and the HTC
Release Date
January 10, 2024
Expiration Date
5:00 PM Eastern, January 9, 2026
The estimated time to complete this enduring material is 30 minutes.
Purpose Statement
The purpose of this module is to examine the 340B Pharmacy Program, its role in homecare of hemophilia, eligibility and enrollment, restrictions and requirements, and special considerations for operation of such a program.
As designated in The Veterans Health Care Act of 1992 designated federally-recognized and federally-funded Hemophilia Diagnostic and Treatment Centers (HTCs) as covered entities eligible to participate in the 340B Drug Pricing Program. HTCs were henceforth able to utilize the 340B Program to stretch federal grant funding and develop capacity to provide robust, comprehensive services to all patients served. In 2015 federal grants divided among 140+ HTCs in the U.S. totaled only $4.9 million from Health Resources and Services Administration (HRSA) (to be used for services not covered by insurance) and an additional $5 million from the Centers for Disease Control and Prevention (CDC) (earmarked for surveillance and research).1 Thus, in this era of fiscal constraint brought on by budget cuts and the effects of federal sequestration, HTC participation in the 340B Pharmacy Program has provided a critical means of financial support for HTC services enabling provision of comprehensive care for all patients seen at HTCs with these programs. Approximately 100 of the 140 HTCs participate in the 340B Pharmacy Program.2 As a condition of participation, these centers must invest all revenues from the program back into patient services, care coordination, research and other programs that directly benefit patients.
Activity Description
This module will provide a brief history of?the 340B Pharmacy Program established in 1992 under the Veterans Healthcare Act and the role of these programs in lowering costs of care and providing revenue for the HTC which must be reinvested into programs and services provided directly to HTC patients. For those HTCs in consideration of starting a 340B Pharmacy Program, this module also introduces the Office of Pharmacy Affairs requirements and regulations for such a program, including definitions of key terms and information about the application process, program maintenance, and potential program audits. Finally, this module will recommend the Hemophilia Alliance as a resource for HTCs with 340B Pharmacy Programs as well as those who are interested in learning more about the operation and management of such programs at HTCs.?
Target Audience
This accredited continuing education activity is designed for nurses, pharmacists, pharmacy technicians, and other healthcare professionals in the U.S. Hemophilia Treatment Center (HTC) Network who wish to learn more about establishing and/or managing a 340B Pharmacy Program and the role of these programs in the U.S. HTC Network.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Explain homecare provision and the role of the 340B Pharmacy Program
- Summarize the importance of Section 340B of the Veterans Health Care Act
- Describe 340B Pharmacy Program eligibility and enrollment
- Identify restrictions and requirements to operate a 340B Pharmacy Program
- Discuss special considerations of operating a 340B Pharmacy Program at a federally-recognized U.S. Hemophilia Treatment Center (HTC).
Faculty
- Jeff Blake, MBA, CEBS
- Madhu Koneru, PharmD
Requirements for Successful Completion
In order to receive continuing education credit, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity
- Complete the evaluation
- Complete the post-test with a score of 70% or better
- Upon successful completion of the post-test your certificate of completion will be available to print or save
In order for pharmacists/pharmacy technicians to claim credit for their participation in the activity, completion of the activity evaluation survey with inclusion of birth date (mm/dd) and NABP e-Profile ID # is required. UNMC will ensure that the data is provided to CPE Monitor.
Accredited Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHARMACISTS (PharmDs/RPhs) AND PHARMACY TECHNICIANS
The University of Nebraska Medical Center designates this activity for 0.5 ACPE contact hours. Pharmacists/Pharmacy Technicians should claim only the credit commensurate with the extent of their participation in the activity.?UAN # JA0000319-9999-24-004-H03-P / UAN # JA0000319-9999-24-004-H03-T
NURSES/NURSE PRACTITIONERS
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 463-238-1186 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
A School Nurse's Guide to Sickle Cell Disease
- Credits: 1.0 (ANCC)
- Expiration Date: August 18, 2025
A School Nurse's Guide to Sickle Cell Disease Details
Activity Number and Title
23HT00132 - A School Nurse's Guide to Sickle Cell Disease
Release Date
August 18, 2023
Expiration Date
5:00 PM Eastern, August 18, 2025
The estimated time to complete this enduring material is 30 minutes.
Purpose Statement
The purpose of this activity is to enable the learner to gain knowledge on the etiology, symptoms, treatment of sickle cell disease, and management strategies in order to optimize safety and learning for affected students.
Activity Description
This module will present the causes, disease traits, inheritance, and symptoms of sickle cell disease (SCD). In addition, common problems and complications of SCD including pain, stroke, priapism, acute chest syndrome, infection, bone disease, eye disease, and other health problems will be provided. Strategies and special accommodations that can be used in the school setting will also be presented.
Target Audience
This accredited continuing education activity is designed for professional school nurses in schools attended by a child with sickle cell disease (SCD), teachers, physical education teachers, administrators and guidance counselors, and other school staff or health care professionals who require an introduction to school-related considerations for students with SCD.
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
- Describe basic information related to the etiology and symptoms of sickle cell disease (SCD)
- Identify common challenges for students with SCD and interventions utilized within the school setting
- Integrate strategies and accommodations in the school setting to promote a safe and positive learning environment for students with sickle cell disease
Faculty
- Ellen Bloom, MPH, CHES
- Kisha Hampton, MPH
Requirements for Successful Completion
In order to receive continuing education credit, you must complete these steps prior to the activity expiration date.
- Read the Disclosure Information found in the To Dos section.
- Complete the learning activity.
- Complete the evaluation.
- Complete the post-test with a score of 70% or better.
- Upon successful completion of the post-test your certificate of completion will be available to print or save.
Accreditation Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Indiana Hemophilia and Thrombosis Center. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 0.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Financial Support
No commercial support was received for this activity.
Contact Information
If you have any questions about this activity, please contact Brooke Hernandez in Indianapolis, IN, 317-871-0011 ext. 813 or via email at bhernandez@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.
System Requirements
- 2 gigabytes of RAM
- High-speed internet connection
- Internet browser (current version) Firefox, Safari, Chrome, or Edge
- Cookies and JavaScript must be enabled in the browser
The Partners in Bleeding Disorders Education Program is supported by an independent medical education grant(s). Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia & Thrombosis Center.
Copyright © 2024 Indiana Hemophilia & Thrombosis Center. All rights reserved. Privacy Policy | Travel Policy | Terms of Service Credits